AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 117 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,480,000 | +8.2% | 71,609 | +17.0% | 0.01% | +7.7% |
| Q2 2017 | $3,217,000 | +36.1% | 61,227 | +17.5% | 0.01% | +30.0% |
| Q1 2017 | $2,364,000 | +12.3% | 52,123 | -6.3% | 0.01% | +11.1% |
| Q4 2016 | $2,106,000 | -8.8% | 55,653 | -9.0% | 0.01% | -10.0% |
| Q3 2016 | $2,308,000 | +65.0% | 61,153 | -23.1% | 0.01% | +66.7% |
| Q2 2016 | $1,399,000 | +49.5% | 79,473 | +3.2% | 0.01% | +50.0% |
| Q1 2016 | $936,000 | -31.4% | 76,983 | +37.3% | 0.00% | -33.3% |
| Q4 2015 | $1,365,000 | +115.0% | 56,078 | +56.6% | 0.01% | +100.0% |
| Q3 2015 | $635,000 | +0.5% | 35,813 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $632,000 | -33.3% | 35,813 | +18.4% | 0.00% | -25.0% |
| Q1 2015 | $948,000 | +6.6% | 30,239 | -0.7% | 0.00% | 0.0% |
| Q4 2014 | $889,000 | +40.7% | 30,451 | -0.2% | 0.00% | +33.3% |
| Q3 2014 | $632,000 | -6.5% | 30,524 | +11.9% | 0.00% | 0.0% |
| Q2 2014 | $676,000 | +26.6% | 27,286 | +8.3% | 0.00% | +50.0% |
| Q1 2014 | $534,000 | +413.5% | 25,193 | +334.7% | 0.00% | – |
| Q4 2013 | $104,000 | – | 5,795 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |